Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2008-02-21
- Lead Sponsor
- Genaissance Pharmaceuticals
- Target Recruit Count
- 410
- Registration Number
- NCT00285376
- Locations
- 🇺🇸
Pharmacology Research Institute, Riverside, California, United States
🇺🇸Atlanta Institute of Medicine & Research, Marietta, Georgia, United States
🇺🇸Summit Research Network (Michigan), Inc., Flint, Michigan, United States
News
No news found